Kolexia
Conter Cecile
Pédiatrie
Centre Léon-Bérard
Lyon, France
159 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs embryonnaires et germinales Tumeurs du cerveau Tumeurs de l'ovaire Médulloblastome Récidive tumorale locale Gliome Tumeurs du testicule Germinome Tumeurs du cervelet

Industries

SERB
1 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

PROFILER: Program to Establish the Genetic and Immunologic Profile of Patient's Tumor for All Types of Advanced Cancer
Essai Clinique (Centre Léon-Bérard)   01 mars 2024
MOSAÏQUE: Screening for Chromosomal Microarrangements by CGH-array in Developmental Anomalies of the Skin Suggestive of Mosaicism. National Multicentre Descriptive Study.
Essai Clinique (CHU Dijon-Bourgogne)   20 février 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
MOST plus: A Two-period, Multicenter, Randomized, Open-label, Phase II Study Evaluating the Clinical Benefit of a Maintenance Treatment Targeting Tumor Molecular Alterations in Patients With Progressive Locally-advanced or Metastatic Solid Tumors
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
European journal of cancer (Oxford, England : 1990)   01 février 2024
RETINO2011: Conservative Treatments of Retinoblastoma
Essai Clinique (Institut Curie)   29 janvier 2024
Oncological and endocrinological outcomes for children and adolescents with testicular and ovarian sex cord-stromal tumors. Results of the TGM13 National Registry.
Pediatric blood & cancer   23 janvier 2024
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors.
European journal of cancer (Oxford, England : 1990)   06 janvier 2024
Tumeurs germinales : harmonisation des pratiques
Edimark   19 décembre 2023
Antiseizure effect of MEK inhibitor in a child with neurofibromatosis type 1-Developmental and epileptic encephalopathy and optic pathway glioma.
Epileptic disorders : international epilepsy journal with videotape   20 novembre 2023